ANRO Alto Neuroscience, Inc.
NYSE · SEC CIK 1999480 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 53 since 2024-02-05, latest 2026-05-29 16:16
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Smith Nicholas Conrad | CFO, CBO | — | — |
| Etkin Amit | Pres AND CEO, Dir | — | — |
Transactions 19
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 17:06 | 2026-05-14 | ANRO | Etkin Amit | Pres AND CEO, Dir | G - Gift | $0.00 | -400.0K | 833.9K | -32% | $0 | |
| 2026-03-03 | 2026-03-01 | ANRO | Etkin Amit | Pres AND CEO, Dir | F - Tax | $19.69 | -6,227 | 1.23M | -0.5% | -$122.6K | |
| 2026-03-03 | 2026-03-01 | ANRO | Smith Nicholas Conrad | CFO, CBO | F - Tax | $19.69 | -2,806 | 24.1K | -10% | -$55.3K | |
| MI | 2024-07-11 | 2024-07-09+ | ANRO | Savitz Adam | Chief MEDICAL Off | P - Purchase | $12.72 | +15.0K | 36.9K | +68% | +$190.8K |
| M | 2024-04-01 | 2024-03-28 | ANRO | Smith Nicholas Conrad | CFO | P - Purchase | $16.36 | +6,150 | 26.9K | +30% | +$100.6K |
| DI | 2024-03-06 | 2024-02-06 | ANRO | Apeiron Investment Group Ltd. | See Remarks | C - Cnv Deriv | — | +674.7K | 674.7K | New | — |
| D | 2024-03-06 | 2024-02-06 | ANRO | Apeiron Investment Group Ltd. | See Remarks | C - Cnv Deriv | — | +251.9K | 251.9K | New | — |
| D | 2024-03-05 | 2024-03-01 | ANRO | Etkin Amit | Pres AND CEO, Dir | A - Grant | $0.00 | +34.7K | 1.24M | +3% | $0 |
| D | 2024-03-05 | 2024-03-01 | ANRO | Smith Nicholas Conrad | CFO | A - Grant | $0.00 | +19.2K | 20.7K | +1,225% | $0 |
| DI | 2024-02-08 | 2024-02-06 | ANRO | Alpha Wave Global, LP | 10% | P - Purchase | $16.00 | +600.0K | 3.71M | +19% | +$9.60M |
| DMI | 2024-02-08 | 2024-02-06 | ANRO | Alpha Wave Global, LP | 10% | C - Cnv Deriv | — | +3.11M | 1.96M | New | — |
| 2024-02-07 | 2024-02-06 | ANRO | Smith Nicholas Conrad | CFO | P - Purchase | $16.00 | +1,563 | 1,563 | New | +$25.0K | |
| DMI | 2024-02-07 | 2024-02-06 | ANRO | Cox Christopher Nixon | Dir | C - Cnv Deriv | — | +715.7K | 588.9K | New | — |
| D | 2024-02-07 | 2024-02-06 | ANRO | Etkin Amit | Pres AND CEO, Dir | P - Purchase | $16.00 | +3,125 | 1.21M | +0.3% | +$50.0K |
| D | 2024-02-07 | 2024-02-06 | ANRO | Etkin Amit | Pres AND CEO, Dir | C - Cnv Deriv | — | +11.8K | 1.20M | +1.0% | — |
| DM | 2024-02-07 | 2024-02-06 | ANRO | Chen Po Yu (Jeff) | Dir | C - Cnv Deriv | — | +47.7K | 39.3K | New | — |
| D | 2024-02-07 | 2024-02-06 | ANRO | York Gwill | Dir | C - Cnv Deriv | — | +23.9K | 23.9K | New | — |
| DI | 2024-02-07 | 2024-02-06 | ANRO | Savitz Adam | Chief MEDICAL Off | P - Purchase | $16.00 | +17.0K | 24.9K | +217% | +$272.0K |
| DI | 2024-02-07 | 2024-02-06 | ANRO | Savitz Adam | Chief MEDICAL Off | C - Cnv Deriv | — | +7,851 | 7,851 | New | — |
Purchase Sale Sale after option exercise All abbreviations